Bello I, Sandiumenge A, Coll E, et al. - In view of the immunomodulatory and antiinflamatory effects of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, researchers here examined if incidence of primary graft dysfunction (PGD) after  lung transplant (LT) decreases in correlation with recipient's preoperative statin therapy. In this multicenter retrospective analysis, 474 adult LT recipients were reviewed. Of these, 110 were on statin treatment. PGD developed in a total of 161 patients (34%), without significant differences between groups (32.2% vs 39%). Outcomes, however, revealed reduced severity of PGD in those on statin treatment.